“The anti-angiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma”

Marina Pagnuzzi‐Boncompagni(Scientific Centre of Monaco), Gilles Pagès(Inserm)
bioRxiv (Cold Spring Harbor Laboratory)
September 19, 2020
Cited by 2


Related Papers